Active, Not Recruiting
Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer
NCT03971409
- Conditions
- Breast Diseases, Breast Neoplasms, Invasive Breast Carcinoma, +13 more
- Locations
-
- O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
- University of California, San Francisco San Francisco, California, United States
- Georgetown University Washington D.C., District of Columbia, United States
- University of Chicago Medicine Comprehensive Cancer Center Evergreen Park, Illinois, United States